Mismatch repair–deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade

Parenchymal brain metastases from prostate cancer are unusual and are associated with poor prognosis. Given the rarity of this entity, little is known about its molecular and histologic characteristics. Here we describe a patient with metastatic castration-resistant, mismatch repair–deficient (dMMR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sena, Laura A., Salles, Daniela C., Engle, Elizabeth L., Zhu, Qingfeng, Tukachinsky, Hanna, Lotan, Tamara L., Antonarakis, Emmanuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327884/
https://www.ncbi.nlm.nih.gov/pubmed/34140335
http://dx.doi.org/10.1101/mcs.a006094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327884/
https://www.ncbi.nlm.nih.gov/pubmed/34140335
http://dx.doi.org/10.1101/mcs.a006094

Ejemplares similares